KATHERINE TORRES: Open Payments
NPI 1780332338 · JENSEN BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,629 in 67 payments from 24 companies in 2025. Trend: 2023 $3,787 · 2024 $4,155 · 2025 $1,629
Food & beverage: $1,629
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 6 | $287 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $154 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| GlaxoSmithKline, LLC. | 5 | $109 |
| United Therapeutics Corporation | 5 | $103 |
| Verona Pharma, Inc. | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Paratek Pharmaceuticals, Inc. | 4 | $59 |
| Insmed, Inc. | 2 | $56 |
Products named: UPTRAVI, Tyvaso, Ohtuvayre, NUCALA, DUPIXENT, HYQVIA, OFEV, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
